Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1989 1
1991 1
1992 1
1993 5
1994 4
1995 8
1996 3
1997 8
1998 25
1999 24
2000 39
2001 54
2002 109
2003 137
2004 127
2005 129
2006 165
2007 167
2008 155
2009 179
2010 195
2011 204
2012 215
2013 194
2014 249
2015 224
2016 303
2017 323
2018 368
2019 369
2020 426
2021 462
2022 458
2023 449
2024 496
2025 220

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,752 results

Results by year

Filters applied: . Clear all
Page 1
Imiquimod for Cervical and Vaginal Intraepithelial Neoplasia: A Systematic Review and Meta-analysis.
Inayama Y, Takamatsu S, Hamanishi J, Mizuno K, Horinouchi N, Yamanoi K, Taki M, Murakami R, Yamaguchi K, Kosaka K, Efthimiou O, Kawakami K, Furukawa TA, Mandai M. Inayama Y, et al. Obstet Gynecol. 2023 Aug 1;142(2):307-318. doi: 10.1097/AOG.0000000000005256. Epub 2023 Jul 5. Obstet Gynecol. 2023. PMID: 37411024 Free article.
We estimated pooled odds ratios (ORs) of imiquimod, compared with placebo or no intervention. We also conducted a meta-analysis of the proportions of patients with adverse events in the imiquimod arms. ...An additional four studies were available for meta-analyses o …
We estimated pooled odds ratios (ORs) of imiquimod, compared with placebo or no intervention. We also conducted a meta-analysis of th …
Imiquimod-Associated Pemphigus Foliaceus.
Farid MRA, Lugão HB, Julio TA, Donadi EA, Bueno Filho R, Roselino AM. Farid MRA, et al. Am J Ther. 2022 Nov-Dec 01;29(6):e716-e719. doi: 10.1097/MJT.0000000000001251. Epub 2020 Oct 1. Am J Ther. 2022. PMID: 33021541 No abstract available.
Imiquimod for vaginal intraepithelial neoplasia 2-3: A systematic review and meta-analysis.
Inayama Y, Yamanishi Y, Nakatani E, Aratake J, Sasagasako N, Yamada K, Gou R, Kawamura A, Yamanishi M, Kosaka K. Inayama Y, et al. Gynecol Oncol. 2021 Jan;160(1):140-147. doi: 10.1016/j.ygyno.2020.09.031. Epub 2020 Oct 1. Gynecol Oncol. 2021. PMID: 33010966
This study aimed to investigate the efficacy of imiquimod in VaIN 2-3. METHODS: Electronic databases (PubMed, EMBASE, ClinicalTrials.gov, and Cochrane Central Register of Controlled Trials) were searched from their inception until October 2019 and articles reporting imi
This study aimed to investigate the efficacy of imiquimod in VaIN 2-3. METHODS: Electronic databases (PubMed, EMBASE, ClinicalTrials. …
Imiquimod as Local Immunotherapy in the Management of Premalignant Cutaneous Conditions and Skin Cancer.
Garcia-Mouronte E, Berna-Rico E, de Nicolas-Ruanes B, Azcarraga-Llobet C, Alonso-Martinez de Salinas L, Bea-Ardebol S. Garcia-Mouronte E, et al. Int J Mol Sci. 2023 Jun 29;24(13):10835. doi: 10.3390/ijms241310835. Int J Mol Sci. 2023. PMID: 37446011 Free PMC article. Review.
Due to the great array of clinical conditions, their worldwide increasing incidence and the steady ageing of the population, non-invasive treatments modalities that show a good clinical response, a proper benefit-risk ratio and cosmetic results are becoming increasingly important …
Due to the great array of clinical conditions, their worldwide increasing incidence and the steady ageing of the population, non-invasive tr …
Imiquimod-induced extensive plaque psoriasis.
Abreu EP, Schwan NV, Gontijo JRV, Bittencourt FV. Abreu EP, et al. Int J Dermatol. 2023 Dec;62(12):e614-e615. doi: 10.1111/ijd.16820. Epub 2023 Aug 28. Int J Dermatol. 2023. PMID: 37638544 No abstract available.
Imiquimod to prevent keloid recurrence postexcision: A systematic review and meta-analysis.
Klotz T, Munn Z, Aromataris EC, Greenwood JE. Klotz T, et al. Wound Repair Regen. 2020 Jan;28(1):145-156. doi: 10.1111/wrr.12766. Epub 2019 Oct 21. Wound Repair Regen. 2020. PMID: 31587416
Imiquimod 5% cream, an immune response modifier capable of inducing IFN-alpha, TNF-alpha, and interleukins 1, 6, and 8. ...For keloids excised from other areas (predominantly on the trunk) recurrence rate was higher, at 76.8% (95% CI = 36.1-100%). For keloids, Imiquimod
Imiquimod 5% cream, an immune response modifier capable of inducing IFN-alpha, TNF-alpha, and interleukins 1, 6, and 8. ...For keloid
Imiquimod-induced hypertrophic lupus erythematosus-like reaction.
Safadi MG, Hassan S, Patel V, Viglione M, Zahner SL. Safadi MG, et al. Dermatol Online J. 2022 Aug 15;28(4). doi: 10.5070/D328458526. Dermatol Online J. 2022. PMID: 36259863 Free article.
Imiquimod is also used off-label for nodular BCC, cutaneous T-cell lymphoma, pyogenic granuloma, and melanoma. Imiquimod-induced lupus-like reactions have been reported. However, hypertrophic lupus erythematosus (HLE) is a rare variant of cutaneous lupus and imiq
Imiquimod is also used off-label for nodular BCC, cutaneous T-cell lymphoma, pyogenic granuloma, and melanoma. Imiquimod-induc
Dietary Fiber Inulin Improves Murine Imiquimod-Induced Psoriasis-like Dermatitis.
Yoshida M, Funasaka Y, Saeki H, Yamamoto M, Kanda N. Yoshida M, et al. Int J Mol Sci. 2023 Sep 17;24(18):14197. doi: 10.3390/ijms241814197. Int J Mol Sci. 2023. PMID: 37762500 Free PMC article.
We examined if feeding with an inulin-enriched high-fiber diet (HFD) might improve topical imiquimod-induced psoriasis-like dermatitis in mice. HFD reduced thickening and total severity scores of imiquimod-induced dermatitis and reduced epidermal thickness, inflamma …
We examined if feeding with an inulin-enriched high-fiber diet (HFD) might improve topical imiquimod-induced psoriasis-like dermatiti …
Topical Imiquimod as a Treatment Option for Nodular Basal Cell Carcinoma: A Systematic Review.
Huang CM, Kirchhof MG. Huang CM, et al. J Cutan Med Surg. 2020 Sep/Oct;24(5):495-503. doi: 10.1177/1203475420931770. Epub 2020 Jun 11. J Cutan Med Surg. 2020. PMID: 32527151
However, patients who reject or are unsuited for surgery may benefit from imiquimod (IMQ) 5% cream as an alternative treatment. OBJECTIVES: The objective of this study was to conduct a systematic review on the efficacy and safety of IMQ for the treatment of nBCC. MATERIALS …
However, patients who reject or are unsuited for surgery may benefit from imiquimod (IMQ) 5% cream as an alternative treatment. OBJEC …
5,752 results